2024 Rome, Italy

III-066 Carlos Perez-Ruixo
A Mechanism-Based PK/PD Model for Posdinemab (JNJ-63733657), a Humanized Monoclonal Antibody Targeting pTau, in healthy and Alzheimer’s Disease Subjects
Thursday 09:50-11:20